GenixPharmaceucticals Corporation

Research GenixPharmaceucticals Corporation (GENX) on Bullrun: market cap CAD 1.22M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CAD 1.22M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025n/an/a-CAD 125.89Kn/an/aCAD 43.59KCAD 1.04M-CAD 1.42M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23CAD 1.22Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 CAD.

About GenixPharmaceucticals Corporation

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is GenixPharmaceucticals Corporation's market cap?

GenixPharmaceucticals Corporation's market capitalization is CAD 1.22M.

What does GenixPharmaceucticals Corporation do?

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops.